ORIGINAL ARTICLEComparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients
Introduction
Both enteral and parenteral artificial nutritional support are nowadays common practices in the treatment of critically ill patients. Early enteral nutrition (EN) appears to have advantages over parenteral nutrition because it costs less, causes less atrophy in the structure of the intestinal mucosa, has a lower infection rate and reduces bacterial translocation and sepsis 1., 2., 3., 4., 5., although the frequency of gastrointestinal complications is high 6., 7.. However, although the use of standard products for EN is universally accepted, the role of what is known as disease-specific nutrition is still controversial 8., 9., 10.. Critically ill patients show a stereotyped metabolic response to injury which causes changes in the carbohydrate metabolism 11., 12. with increased gluconeogenesis, enhanced peripheral glucose uptake and utilization, insulin resistance and inversion of the glucagon/insulin ratio, leading to hyperglycemia favored by the action of counterregulatory hormones 13., 14.. There is also an increase in fat oxidation with lipolysis (15) and an increase in proteolysis with loss of nitrogen (16). Thus, in these patients, the stress metabolic response is characterized by hyperglycemia, fat mobilization and protein breakdown.
The composition of enteral formulas for hospitalized diabetic patients is still controversial 17., 18., 19., since it is postulated that standard high-carbohydrate, low-fat diets may not be appropriate in short-to-medium term treatment since they may impair glycemic control. Studies of diets with higher percentage of fat to carbohydrates appear to show improved glycemic control when compared to standard diets 17., 19., 20.. However, the type and amount of fiber needed by diabetic patients on liquid diets has not yet been satisfactorily established (21), and the percentage of monounsaturated fatty acids (MUFA) and total fat that should be recommended remain unclear 22., 23.. There are also very few studies of long-term EN treatment in diabetic patients and even fewer on hyperglycemic critically ill patients 19., 20., 24., 25..
The importance of avoiding overfeeding in the critically ill patient has been postulated (26), but in patients who also have hyperglycemia the role of specific diets in the control of their carbohydrate, lipid and protein metabolism has not yet been demonstrated, especially in long term treatments. We hypothesized that a disease-specific diet in hyperglycemic critically ill patients may allow a better glycemic control than a non-disease-specific diet. Thus, the aim of this study was to evaluate if the administration of a disease-specific high-protein formula with similar caloric percentage of fat and carbohydrates to hyperglycemic critically ill patients achieves greater control of glycemia and reduces insulin requirements when compared to a conventional high-protein formula. The main differences between them were related to the content and type of carbohydrates, the content and type of fat, and the addition or lack of dietary fiber.
Section snippets
Material and methods
A prospective, randomized, controlled, single-blind, clinical trial was conducted in the ICU wards of two university hospitals in Spain. The study protocol was approved by the Institutional Review Board and each patient or the closest relative provided written informed consent to participate.
The primary endpoints for this study were glycemic control, keeping plasma glucose levels between 100 and 200 mg/dl and insulin/day requirements, adapting insulin infusion to capillary glucose levels every 6
Results
Of the 61 patients initially selected to participate in the study, five refused to give the informed consent, four died before randomization and two suffered acute gastrointestinal bleeding which prevented enteral feeding. Of the remaining 50 patients, 26 were allocated to the study group and 24 to the control group. One patient in the study group and three patients in the control group did not achieve the minimum 5 days of nutrition established in the protocol, in one case due to death and in
Discussion
The use of a high-protein disease-specific formula with a similar caloric percentage of fat and carbohydrates in hyperglycemic critically ill patients improves glycemic metabolism control with lower plasma glucose levels, capillary glucose levels and insulin requirements compared with a control high-protein diet, thus confirming the initial hypothesis. However, Table 5 shows no significant interaction between the effect of the formula and the prognostic variables such as the presence of sepsis
Conclusions
Enteral nutrition in the hyperglycemic critically ill patient with a disease-specific high protein diet, with similar caloric percentage of fat and carbohydrates produces a significant reduction in plasma glucose levels, capillary glucose levels and insulin requirements in comparison with a conventional high-protein diet.
There are no significant differences in the rate of acquired infections, ICU length of stay, days of mechanical ventilation or mortality between the groups. Gastrointestinal
Acknowledgements
We would like to thank Mireia Morera, MD, for her helpful advice and encouragement. The statistical analysis of this research was supported by Novartis Consumer Health, Spain.
References (37)
- Moore F A, Moore E E, Jones T N, McCroskey B L, Peterson V M. TEN versus TPN following major abdominal trauma reduced...
- Kudks K A, Croce M A, Fabian T C et al. Enteral vs parenteral feeding: effects on septic morbidity after blunt and...
- Moore F A, Feliciano D V, Andrassy R J et al. Early enteral feeding, compared with parenteral, reduces postoperative...
- Heyland D K, Cook D J, Guyatt G H. Enteral nutrition in the critically ill patient: a critical review of the evidence....
- Hadfield R J, Sinclair D G, Houldsworth P E, Evans T W. Effects of enteral and parenteral nutrition on gut mucosal...
- Heyland D, Cook D J, Winder B, Brylowski L, Van deMark H, Guyatt G. Enteral nutrition in the critically ill patient: a...
- Montejo J C for the Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and...
- Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M, Twomey P. Nutrition support in clinical practice:...
- Heyland D K, Novak F. Immunonutrition in the critically ill patient: more harm than good? J Parenter Enteral Nutr 2001;...
- Galban C, Montejo J C, Mesejo A et al. An immune-enhancing enteral diet reduces mortality rate and episodes of...
Cited by (82)
High-fat low-carbohydrate enteral feeding enriched with olive oil and acute respiratory failure: A double-blind, randomized, controlled trial
2022, Clinical Nutrition ESPENCitation Excerpt :Contrary to our study, Mesejo et al., in 2002 enrolled 50 critically ill patients with hyperglycemia to receive a high protein, high fat formula or a high protein formula for 14 days. Their results proved that the duration of mechanical ventilation was not affected with high fat formula [16]. In the post-hoc study of PermiT trial in 2018, 120 critically ill patients with hypercapnic ARF were randomized to receive either permissive underfeeding or isocaloric feeding with similar protein intake.
Association of specialized enteral nutrition with glycemic control and clinical outcomes in critically ill patients: A meta-analysis of randomized controlled trials
2021, Clinical NutritionCitation Excerpt :Most studies [35,37–39,41–44] included patients on MV at baseline. In seven studies [35–38,41,43,44] the prevalence of previous diabetes was ≤50% whereas three studies [38,39,42] included no patients with diabetes. The use of corticosteroids was reported in three studies [36,41,44] and insulin therapy protocols were described in seven studies [35,36,38,40–42,44].
Diabetes-specific formulas high in monounsaturated fatty acids and metabolic outcomes in patients with diabetes or hyperglycaemia. A systematic review and meta-analysis
2020, Clinical NutritionCitation Excerpt :The route of administration in all MLFU studies was continuous tube feed [26–34,36], except for two [25,35]. The differences in total fat content between the DSFs and the STDFs was 26% [31], 19%–20% [25,29,32,34,35], 15%–16% [19,33,36], 10%–11% [28,30,32], 8% [26] and 4.5% [27] (Table 1). Table 3 and Fig. 3 show the effect sizes observed for metabolic outcome measures in included studies.
Clinical Nutrition in Critical Care Medicine – Guideline of the German Society for Nutritional Medicine (DGEM)
2019, Clinical Nutrition ESPENGlycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients
2019, Clinical NutritionCitation Excerpt :Nutrition support in ICU is a standard aspect of clinical care and usually entails formula fed through a tube or an intravenous infusion in patients who are on ventilator support. A reduction in glycaemic load by using a diabetes specific formula is associated with a reduction in the requirement for exogenous insulin and an improvement in glycaemic variability [24–26]. In addition to this, low carbohydrate formulae were also historically used to assist with management of hypercapnea [27,28].